Chemo Pharma Laboratories Share Price
₹89.25 -2.15 (-2.35%)
25 Jan, 2025 22:02
Start SIP in CHEMOPH
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month -13.45%
- Over 3 Month + 35.06%
- Over 6 Month + 23.1%
- Over 1 Year + 16.67%
Smart Investing Starts Here Start SIP with Chemo Pharma Laboratories for Steady Growth!
Chemo Pharma Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Chemo Pharma Laboratories Financials
Chemo Pharma Laboratories Technicals
EMA & SMA
Current Price
₹89.25
-2.15
(-2.35%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹95.81
- 50 Day
- ₹94.63
- 100 Day
- ₹88.14
- 200 Day
- ₹79.14
Resistance and Support
89.98
- R3 99.87
- R2 96.73
- R1 93.12
- S1 86.37
- S2 83.23
- S3 79.62
Chemo Pharma Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-27 | Quarterly Results | |
2024-10-28 | Quarterly Results | |
2024-07-29 | Quarterly Results & A.G.M. | |
2024-05-27 | Audited Results | |
2024-01-29 | Quarterly Results & Others | Inter alia, to consider and approve the Re-Appointment of M/s Kavita Khatri & Associates Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2023-24. |
Chemo Pharma Laboratories F&O
About Chemo Pharma Laboratories
- NSE Symbol
- CHEMOPH
- BSE Symbol
- 506365
- ISIN
- INE320M01019
Similar Stocks to Chemo Pharma Laboratories
Chemo Pharma Laboratories FAQs
Chemo Pharma Laboratories share price is ₹89 As on 25 January, 2025 | 21:48
The Market Cap of Chemo Pharma Laboratories is ₹13.4 Cr As on 25 January, 2025 | 21:48
The P/E ratio of Chemo Pharma Laboratories is 10.8 As on 25 January, 2025 | 21:48
The PB ratio of Chemo Pharma Laboratories is 1 As on 25 January, 2025 | 21:48
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.